Skip to main content
Erschienen in: Familial Cancer 1/2015

01.03.2015 | Original Article

Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer

verfasst von: Louise Heiniger, Phyllis N. Butow, Joseph Coll, Tracey Bullen, Judy Wilson, Brandi Baylock, Bettina Meiser, Melanie A. Price

Erschienen in: Familial Cancer | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

This study prospectively investigated long-term psychosocial outcomes for women who opted for risk-reducing mastectomy (RRM) and/or risk-reducing salpingo-oophorectomy (RRSO). Unaffected women from high-risk breast cancer families who had completed baseline questionnaires for an existing study and subsequently underwent RRM and/or RRSO, completed measures of perceived breast and ovarian cancer risk, anxiety, depression, cancer-related anxiety, body image, sexual functioning, menopausal symptoms, use of hormone replacement therapy and decision regret 3 years post-surgery. Outcomes were compared to age- and risk-matched controls. Participants (N = 233) were 17 women who had RRM (39 controls), 38 women who had RRSO (94 controls) and 15 women who had RRM + RRSO (30 controls). Women who underwent RRM and those who underwent RRM + RRSO reported reductions in perceived breast cancer risk and perceived breast and ovarian cancer risk respectively, compared to their respective controls. RRM women reported greater reductions in cancer-related anxiety compared with both controls and RRSO women. RRSO women reported more sexual discomfort than controls and more urogenital menopausal symptoms than controls and RRM only women. No differences in general anxiety, depression or body image were observed. Regret was associated with greater reductions in body image since surgery and more sexual discomfort, although overall regret levels were low. Women who undergo RRM experience psychological benefits associated with reduced breast cancer risk. Although women who undergo RRSO experience some deterioration in sexual and menopausal symptoms, they do not regret their surgery decision. It is vital that women considering these procedures receive detailed information about potential psychosocial consequences.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
Relative risk of one RRS participant was calculated as 0.83 upon entry to kConFab. This participant is not eligible for predictive testing as no deleterious mutation has been identified in the family. Lower age at first child and older age at menarche are associated with relative risks of less than 1 [25].
 
Literatur
2.
Zurück zum Zitat Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62(3):676–689CrossRefPubMedCentralPubMed Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62(3):676–689CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80–87CrossRefPubMedCentralPubMed Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80–87CrossRefPubMedCentralPubMed
4.
Zurück zum Zitat Hallowell N (2000) A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psycho-Oncology 9(6):486–495CrossRefPubMed Hallowell N (2000) A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psycho-Oncology 9(6):486–495CrossRefPubMed
5.
Zurück zum Zitat Hurley KE, Miller SM, Costalas JW, Gillespie D, Daly MB (2001) Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. J Womens Health Gend Based Med 10(2):189–199CrossRefPubMed Hurley KE, Miller SM, Costalas JW, Gillespie D, Daly MB (2001) Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. J Womens Health Gend Based Med 10(2):189–199CrossRefPubMed
6.
Zurück zum Zitat Vodermaier A, Bauerfeind I, Nestle-Kramling C (2006) Prophylactic surgery in women at high risk for breast and ovarian cancer. An overview of the international literature on attitudes, uptake and quality of life. Geburtshilfe Frauenheilkd 66(11):1035–1049. doi:10.1055/s-2006-924303 CrossRef Vodermaier A, Bauerfeind I, Nestle-Kramling C (2006) Prophylactic surgery in women at high risk for breast and ovarian cancer. An overview of the international literature on attitudes, uptake and quality of life. Geburtshilfe Frauenheilkd 66(11):1035–1049. doi:10.​1055/​s-2006-924303 CrossRef
7.
Zurück zum Zitat Elit L, Esplen MJ, Butler K, Narod S (2001) Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam Cancer 1(3–4):149CrossRefPubMed Elit L, Esplen MJ, Butler K, Narod S (2001) Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam Cancer 1(3–4):149CrossRefPubMed
8.
Zurück zum Zitat Metcalfe KA, Narod SA (2002) Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst 94(20):1564–1569CrossRefPubMed Metcalfe KA, Narod SA (2002) Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst 94(20):1564–1569CrossRefPubMed
9.
Zurück zum Zitat Bresser PJC, Seynaeve C, Van Gool AR, Niermeijer MF, Duivenvoorden HJ, van Dooren S et al (2007) The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur J Cancer 43(1):95–103. doi:10.1016/j.ejca.2006.09.009 CrossRefPubMed Bresser PJC, Seynaeve C, Van Gool AR, Niermeijer MF, Duivenvoorden HJ, van Dooren S et al (2007) The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur J Cancer 43(1):95–103. doi:10.​1016/​j.​ejca.​2006.​09.​009 CrossRefPubMed
10.
Zurück zum Zitat Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. J Am Med Assoc 284(3):319–324CrossRef Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. J Am Med Assoc 284(3):319–324CrossRef
12.
Zurück zum Zitat Isern AE, Tengrup I, Loman N, Olsson H, Ringberg A (2008) Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction. J Plast Reconstr Aesthet Surg 61(10):1177–1187. doi:10.1016/j.bjps.2007.08.006 CrossRefPubMed Isern AE, Tengrup I, Loman N, Olsson H, Ringberg A (2008) Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction. J Plast Reconstr Aesthet Surg 61(10):1177–1187. doi:10.​1016/​j.​bjps.​2007.​08.​006 CrossRefPubMed
13.
Zurück zum Zitat Payne DK, Biggs C, Tran KN, Borgen PI, Massie MJ (2000) Women’s regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 7(2):150–154CrossRefPubMed Payne DK, Biggs C, Tran KN, Borgen PI, Massie MJ (2000) Women’s regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 7(2):150–154CrossRefPubMed
14.
Zurück zum Zitat Fuller S, Anderson RC (2006) Adjustment issues related to bilateral prophylactic mastectomy in women at elevated risk of developing breast cancer. Plast Surg Nurs 26(2):60–65CrossRefPubMed Fuller S, Anderson RC (2006) Adjustment issues related to bilateral prophylactic mastectomy in women at elevated risk of developing breast cancer. Plast Surg Nurs 26(2):60–65CrossRefPubMed
15.
Zurück zum Zitat Gahm J, Wickman M, Brandberg Y (2010) Bilateral prophylactic mastectomy in women with inherited risk of breast cancer—prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 19(6):462–469. doi:10.1016/j.breast.2010.05.003 CrossRefPubMed Gahm J, Wickman M, Brandberg Y (2010) Bilateral prophylactic mastectomy in women with inherited risk of breast cancer—prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 19(6):462–469. doi:10.​1016/​j.​breast.​2010.​05.​003 CrossRefPubMed
16.
Zurück zum Zitat Robson M, Hensley M, Barakat R, Brown C, Chi D, Poynor E et al (2003) Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol Oncol 89(2):281–287CrossRefPubMed Robson M, Hensley M, Barakat R, Brown C, Chi D, Poynor E et al (2003) Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol Oncol 89(2):281–287CrossRefPubMed
17.
Zurück zum Zitat Madalinska JB, van Beurden M, Bleiker EMA, Valdimarsdottir HB, Hollenstein J, Massuger LF et al (2006) The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 24(22):3576–3582. doi:10.1200/jco.2005.05.1896 CrossRefPubMed Madalinska JB, van Beurden M, Bleiker EMA, Valdimarsdottir HB, Hollenstein J, Massuger LF et al (2006) The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 24(22):3576–3582. doi:10.​1200/​jco.​2005.​05.​1896 CrossRefPubMed
18.
Zurück zum Zitat Fry A, Busby-Earle C, Rush R, Cull A (2001) Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer. Psycho-Oncology 10(3):231–241CrossRefPubMed Fry A, Busby-Earle C, Rush R, Cull A (2001) Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer. Psycho-Oncology 10(3):231–241CrossRefPubMed
19.
Zurück zum Zitat Bebbington Hatcher M, Fallowfield L, A’Hern R (2001) The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. Br Med J 322(7278):76CrossRef Bebbington Hatcher M, Fallowfield L, A’Hern R (2001) The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. Br Med J 322(7278):76CrossRef
20.
Zurück zum Zitat Hopwood P, Lee A, Shenton A, Baildam A, Brain A, Lalloo F et al (2000) Clinical follow-up after bilateral risk reducing (‘prophylactic’) mastectomy: mental health and body image outcomes. Psycho-Oncology 9(6):462–472CrossRefPubMed Hopwood P, Lee A, Shenton A, Baildam A, Brain A, Lalloo F et al (2000) Clinical follow-up after bilateral risk reducing (‘prophylactic’) mastectomy: mental health and body image outcomes. Psycho-Oncology 9(6):462–472CrossRefPubMed
21.
Zurück zum Zitat Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A et al (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26(24):3943–3949CrossRefPubMed Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A et al (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26(24):3943–3949CrossRefPubMed
22.
Zurück zum Zitat Gopie JP, Mureau MAM, Seynaeve C, ter Kuile MM, Menke-Pluymers MBE, Timman R et al (2013) Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer 12(3):479–487. doi:10.1007/s10689-012-9588-5 CrossRefPubMed Gopie JP, Mureau MAM, Seynaeve C, ter Kuile MM, Menke-Pluymers MBE, Timman R et al (2013) Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer 12(3):479–487. doi:10.​1007/​s10689-012-9588-5 CrossRefPubMed
23.
Zurück zum Zitat Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C et al (2011) The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 121(1):163–168CrossRefPubMed Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C et al (2011) The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 121(1):163–168CrossRefPubMed
24.
Zurück zum Zitat Phillips KA, Butow PN, Stewart AE, Chang JH, Weideman PC, Price MA et al (2005) Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 4(2):105–113. doi:10.1007/s10689-004-6129-x CrossRefPubMed Phillips KA, Butow PN, Stewart AE, Chang JH, Weideman PC, Price MA et al (2005) Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 4(2):105–113. doi:10.​1007/​s10689-004-6129-x CrossRefPubMed
26.
Zurück zum Zitat Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1). doi:10.1186/bcr1377 Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1). doi:10.​1186/​bcr1377
27.
Zurück zum Zitat Price MA, Butow PN, Lo SK, Wilson J (2007) Predictors of cancer worry in unaffected women from high risk breast cancer families: risk perception is not the primary issue. J Genet Couns 16(5):635–644CrossRefPubMed Price MA, Butow PN, Lo SK, Wilson J (2007) Predictors of cancer worry in unaffected women from high risk breast cancer families: risk perception is not the primary issue. J Genet Couns 16(5):635–644CrossRefPubMed
28.
Zurück zum Zitat Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J et al (1999) Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 75(1):122–129CrossRefPubMed Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J et al (1999) Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 75(1):122–129CrossRefPubMed
29.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
30.
Zurück zum Zitat Horowitz MJ, Wilner N, Alvarez W (1979) Impact of Event Scale: a measure of subjective stress. Psychosom Med 41(3):209–218CrossRefPubMed Horowitz MJ, Wilner N, Alvarez W (1979) Impact of Event Scale: a measure of subjective stress. Psychosom Med 41(3):209–218CrossRefPubMed
32.
Zurück zum Zitat White CA, Hood C (2012) Body image issues in oncology. In: Cash TF, Smolak L (eds) Body image: a handbook of science, practice, and prevention. Guilford Publications, New York, pp 333–341 White CA, Hood C (2012) Body image issues in oncology. In: Cash TF, Smolak L (eds) Body image: a handbook of science, practice, and prevention. Guilford Publications, New York, pp 333–341
34.
Zurück zum Zitat Schneider H, Heinemann L, Rosemeier H-P, Potthoff P, Behre H (2000) The Menopause Rating Scale (MRS): reliability of menopausal complaints. Climacteric 3:59–64CrossRefPubMed Schneider H, Heinemann L, Rosemeier H-P, Potthoff P, Behre H (2000) The Menopause Rating Scale (MRS): reliability of menopausal complaints. Climacteric 3:59–64CrossRefPubMed
35.
Zurück zum Zitat Brehaut JC, O’Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E et al (2003) Validation of a decision regret scale. Med Decis Mak 23:281–292CrossRef Brehaut JC, O’Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E et al (2003) Validation of a decision regret scale. Med Decis Mak 23:281–292CrossRef
37.
Zurück zum Zitat Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB (2009) A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol 112(3):594–600CrossRefPubMedCentralPubMed Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB (2009) A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol 112(3):594–600CrossRefPubMedCentralPubMed
38.
Zurück zum Zitat den Heijer M, Seynaeve C, Timman R, Duivenvoorden HJ, Vanheusden K, Tilanus-Linthorst M et al (2012) Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. Eur J Cancer 48(9):1263–1268. doi:10.1016/j.ejca.2011.10.020 CrossRef den Heijer M, Seynaeve C, Timman R, Duivenvoorden HJ, Vanheusden K, Tilanus-Linthorst M et al (2012) Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. Eur J Cancer 48(9):1263–1268. doi:10.​1016/​j.​ejca.​2011.​10.​020 CrossRef
Metadaten
Titel
Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer
verfasst von
Louise Heiniger
Phyllis N. Butow
Joseph Coll
Tracey Bullen
Judy Wilson
Brandi Baylock
Bettina Meiser
Melanie A. Price
Publikationsdatum
01.03.2015
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 1/2015
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-014-9759-7

Weitere Artikel der Ausgabe 1/2015

Familial Cancer 1/2015 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.